| scholarly article | Q13442814 |
| P50 | author | Dietmar Vestweber | Q98408 |
| P2093 | author name string | Johan Kuiper | |
| Theo J C van Berkel | |||
| Eva J A van Wanrooij | |||
| M Gabriele Bixel | |||
| Paula de Vos | |||
| P433 | issue | 3 | |
| P921 | main subject | lipoprotein | Q28350 |
| P304 | page(s) | 590-596 | |
| P577 | publication date | 2008-02-04 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice | |
| P478 | volume | 78 |
| Q37709623 | Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases |
| Q38293518 | Antisense oligonucleotides, microRNAs, and antibodies. |
| Q38754143 | CVD and Oxidative Stress |
| Q38137846 | Can we vaccinate against atherosclerosis? |
| Q52691045 | DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice. |
| Q35738533 | DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration. |
| Q43179678 | Effect of oral immunization with pooled antigens derived from adipose tissue on atherosclerosis and obesity indices |
| Q53286737 | IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice. |
| Q46458340 | Immune responses elicited by apoB-100-derived peptides in mice. |
| Q34528035 | Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice |
| Q91404901 | Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model |
| Q52640510 | Live Bacterial Vectors-A Promising DNA Vaccine Delivery System. |
| Q35591762 | Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice |
| Q38125279 | Molecular biology of atherosclerosis |
| Q39003359 | Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular Diseases |
| Q57821678 | Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis |
| Q33663533 | Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study |
| Q64084519 | Targeting Tumor Vascular CD99 Inhibits Tumor Growth |
| Q37530710 | Vaccination for atherosclerosis |
| Q43251127 | Vaccination, atherosclerosis and systemic lupus erythematosus |
| Q33641227 | Vaccine against arteriosclerosis: an update |
Search more.